PCV22 COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN IN PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT IN SLOVAKIA
Abstract
Authors
M Lukac J Bielik M Lees V Foltan D Tomek
M Lukac J Bielik M Lees V Foltan D Tomek
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now